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Abstract
Background Quality of Life (QoL) is an important out-
come measure in oncology. To assess the inﬂuence of sur-
gicaltreatmentandpersonalityonQoLinwomenwithbreast
cancer, a longitudinal prospective cohort study was done.
Methods Women (n = 222) completed questionnaires
concerning QoL (WHOQOL 100) and personality (NEO-
FFIandSTAI)priortothediagnosisofbreastcancerand1,3,
6, and 12 months after diagnosis and treatment. One hun-
dred ﬁve women were treated with breast-conserving ther-
apy (BCT) and 117 women underwent mastectomy (MTC).
Results The two treatment groups did not differ on overall
QoL. At all measurement times the inﬂuence of trait anxiety
on overall QoL was substantial in the BCT group. Women
withahighscoreontraitanxietywereseventimesmorelikely
to have a low overall QoL 1 year after BCT. In the MTC
group overall QoL was inﬂuenced mainly by neuroticism.
Conclusions Personality, especially trait anxiety and
neuroticism, determined patients’ overall QoL scores.
Women with an anxious personality fared worse concern-
ing QoL after breast conserving therapy.
Introduction
Breast cancer is the most frequently diagnosed cancer in
women in the developed countries. In the Netherlands,
11% of women will be diagnosed with breast cancer [1].
Primary treatment for breast cancer is surgery. In early-
stage breast cancer, i.e., a tumor smaller than 5 cm in
diameter and no metastases beyond the axilla (stages I and
II), a woman can choose between breast-conserving ther-
apy (BCT) and mastectomy (MTC). BCT refers to lump-
ectomy and a staging operation of the axillary lymph nodes
followed by radiation therapy of the remaining breast. In
MTC, all breast tissue, including the nipple, is removed
and a staging operation is performed on the axillary lymph
nodes. Depending on tumor characteristics and the pres-
ence of axillary metastases, surgery can be followed by
adjuvant chemotherapy, hormonal therapy, and/or radiation
of the area around the collar bone. The two surgical
treatment modalities have proven to be equal with respect
to long-term survival, although disease-free survival is less
after conserving surgery [2].
Since 1929 physicians have been studying the possibil-
ities and results of breast preservation [3]. In many
instances the predominant reason for its use was that
patients refused the recommended radical mastectomy [4].
Since the long-term follow-up studies from randomized
trials have been published [2], the general opinion among
professional caregivers is that BCT is the more favorable
treatment option since it is less mutilating and, therefore,
may lead to a better quality of life (QoL) compared to the
QoL after a MTC.
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uating the results of cancer treatment. It is a multidimen-
sional concept that measures the satisfaction of a person
with a wide range of aspects [5]. QoL has been studied
extensively in breast cancer patients, and the inﬂuence of
surgical treatment on QoL has been addressed. It is known
that QoL is inﬂuenced by health [5], culture, socioeco-
nomic status, and personality [6]. So far, the relationship
between personality and breast cancer has been studied
only once [7]. This study refers to the same study popu-
lation as the present study and showed that trait anxiety had
a profound inﬂuence on overall QoL and was even more
important for QoL than the diagnosis of breast cancer. The
relationship between surgical treatment, personality, and
overall QoL in breast cancer patients has not been studied
before.
In the present study, QoL was assessed in a prospective
longitudinal setting. Two hypotheses based on previous
publications were studied [7, 8]: (1) compared with MTC,
BCT results in a better QoL and (2) personality, and
especially trait anxiety, will have a signiﬁcant inﬂuence on
QoL for both treatment groups. The major differences
between this study and previously published studies are
that there was a baseline measurement before diagnosis,
focusing on the role of personality factors, and a ques-
tionnaire that assesses all aspects of QoL was used.
Patients and methods
Patients
Women who were referred to the specialized mamma-care
nurse of the St. Elisabeth Hospital, the Maasland Hospital
(patient accrual since August 2004), or the Jeroen Bosch
Hospital (patient accrual since January 2006) with a pal-
pable lump in the breast or an abnormality on screening
mammography between September 2002 and January 2007
were asked to participate in the study. Women who had a
medical history of either benign breast disease or breast
cancer were excluded from the study.
Eight hundred ninety-four women were eligible for
participation in this study. Six hundred eight women (68%)
gave informed consent and completed the ﬁrst set of
questionnaires. Reasons for refusal were the length of the
questionnaires and the amount of stress the women expe-
rienced, which they felt impaired their concentration while
completing the questionnaires. There were no differences
in clinical characteristics (e.g., age, tumor size) between
participants and nonparticipants.
After written informed consent was given and before the
ﬁrst appointment with the surgeon, i.e., before the diag-
nosis was known, the women completed the ﬁrst set of
questionnaires. Subsequently, questionnaires were also
completed 1, 3, 6, and 12 months after diagnosis and
treatment. Participation of the patients in the study was not
known by the treating surgeon and, therefore, the surgeon
did not have any inﬂuence on the treatment and clinical
follow-up.
Procedures
The ﬁrst physical examination was performed by the spe-
cialized mamma-care nurse. When a woman presented with
locally advanced breast cancer or a palpable tumor that
would be too large for BCT if breast cancer is diagnosed,
she was asked not to participate in the study. All other
women were asked to participate by the mamma-care
nurse. The treating surgeon was not involved in the study
and, as a standard policy, did not discuss the study with the
women. Thus, the surgeon could stay professional in sup-
porting the patient in the decision process.
Between the consult with the nurse and the subsequent
mammogram and possible ultrasound, women usually had
to wait 90 min during which time the baseline question-
naires were completed. After diagnosis, women who
refused operation, women who had a tumor too large for
BCT, or women who were treated with neoadjuvant che-
motherapy or hormone therapy were removed from the
study population. Three women refused surgery, and, based
on the initial clinical aspects of the tumor (i.e.,\5c mi n
diameter and no metastasis beyond the ipsilateral axilla),
all women were eligible for BCT. This study started in
2002. Oncoplastic surgery was still being developed so it
was not implemented in the everyday practice of the par-
ticipating hospitals. In later years these procedures have
been used but not during the inclusion period of this study.
Before deciding which treatment to take, three important
aspects were discussed with the patient and her partner: (1)
Overall survival is equal for BCT and MTC. (2) Disease-
free survival after BCT may be shorter, with a recurrence
rate of about 15% in 20 years of follow-up [2]. This
recurrence rate is irrespective of tumor size, but does relate
to the accuracy of the operation. (3) Radiotherapy is
mandatory after BCT and may not be necessary after MTC
depending on the presence of metastases in the axillary
region. When it was clear that the patient understood these
aspects, she was allowed to choose her surgical treatment.
Questionnaires
QoL was assessed using the World Health Organization
QualityofLifeassessmentinstrument-100(WHOQOL-100)
[9, 10], a cross culturally developed generic multidimen-
sional questionnaire. It assesses QoL in six domains (Phys-
ical health, Psychological health, Level of independence,
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eral evaluative facet (Overall quality of life and general
health). The reliability and validity of the instrument are
good [11].
Personality was assessed at baseline using the Neuroti-
cism-Extraversion-Openness Five Factor Inventory (NEO-
FFI) [12, 13], and the trait anxiety scale of the State-and-
Trait-Anxiety-Inventory (STAI) [14, 15]. The NEO-FFI
was developed to study an individual’s personality. Per-
sonality is assessed in the ﬁve domains of the Five Factor
Model: neuroticism, extraversion, openness, agreeableness,
and conscientiousness. The psychometric properties are
good [16]. The STAI was originally developed to investi-
gate anxiety phenomena in ‘‘normal’’ adults, but it has also
proven useful in medical and surgical patients. It measures
two types of anxiety. Trait anxiety, used in the present
study, concerns differences in individuals in the disposition
to respond to stressful situations with varying amounts of
stress. The psychometric characteristics of this question-
naire are well established and considered good [17].
Patients were also asked to complete some questions
concerning demographic factors such as age, marital status,
education, and social economic status. Clinical data were
obtained from the medical records of the included patients.
Statistical procedure
Frequencies were used to present demographic information
on the patients before diagnosis. One-way analyses of
variance and v
2 tests were used to compare the patients in
the BCT, MTC, and conversion (eventually received MTC,
although ﬁrst choice was BCT) groups on baseline char-
acteristics. The predictors of overall QoL were found using
the scores on QoL as the dependent variable and the
demographic (block one), clinical (block 2), and person-
ality characteristics (block 3) as independent variables in a
multivariable regression analysis. The variables that sig-
niﬁcantly inﬂuenced overall QoL were then dichotomized
(high or not-high score) and subsequently entered into a
logistic regression analysis to compute the odds ratio for a
low overall QoL score. General linear model for repeated
measures (GLM) was used to examine scores on overall
QoL over time (1) in patients with BCT and MTC and (2)
in patients high or not on trait anxiety in combination with
surgical treatment (BCT or MTC ?). In each analysis the
characteristics on which the groups appeared to differ at
baseline were used as covariates. g
2 is an effect size that
can be derived from the output of the GLM. An g
2 between
0.01 and 0.06 is a small effect, between 0.06 and 0.13 is a
moderate effect, and 0.14 or higher is a large effect [18].
We needed to include at least 55 patients in one of the
groups to reach a power of 0.80, given that we expected to
ﬁnd a moderate effect size. When differences were found
in the GLM between groups, analyses of variance were
used to examine QoL differences between groups at one
particular measurement time. Again, the characteristics on
which the groups differed at baseline were incorporated in
the analyses as covariates. A P\0.05 is considered sta-
tistically signiﬁcant. All analyses were performed using the
SPSS v14.0 (SPSS, Inc., Chicago, IL).
Results
Of the 608 women who entered the study, 225 were
diagnosed with early-stage breast cancer (i.e.,
tumor\5 cm in diameter and no metastases beyond the
ipsilateral axilla) and thus could choose between BCT and
MTC surgery. Three patients refused operation and were
not included in the analyses, leaving 222 patients. The
remaining 383 women appeared to have benign breast
problems and were left out of the analyses.
One hundred thirty-three women chose BCT and 89
patients opted for MTC. In two of the three participating
hospitals, immediate reconstruction after MTC is not
offered to the patients. However, when women request
immediate reconstruction, it is possible. None of the
included patients in any of the three hospitals underwent
immediate reconstruction. Due to incomplete removal of
the tumor or multifocality established by pathological
examination, 57 BCT patients needed additional surgery of
whom 28 eventually had complete removal of the breast.
Whenever possible, these 57 women had the choice
between breast-conserving surgery and mastectomy. These
subsequent surgeries were performed within 3-4 weeks
after the ﬁrst operation. This latter group is referred to as
the conversion group.
There were no differences between the BCT, the MTC,
and the conversion group with regard to demographic
factors (Table 1). With respect to clinical factors there
were signiﬁcant differences. Women in the MTC group and
the conversion group had larger tumors on radiology and
after surgery. A larger percentage of the women in the
MTC group were diagnosed with axillary metastases and
thus received chemotherapy and/or hormonal therapy more
often than the BCT and conversion groups. Since radio-
therapy is part of the conserving treatment, the BCT group
received radiotherapy more often compared with the other
two groups (Table 1). Radiotherapy of the axilla and the
area of the ipsilateral clavicula was done when more than
three lymph nodes contained metastasis; this was the sit-
uation in 5 women in the BCT group, 19 women in the
MTC group, and 5 women in the conversion group.
The groups did not differ with regard to overall QoL or
the QoL domains. With regard to personality, the conver-
sion group scored signiﬁcantly lower on neuroticism
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123compared with the BCT and MTC groups (P = 0.044)
(Table 2).
Because there were no differences between the MTC
group and the conversion group with respect to demo-
graphic factors, clinical factors, QoL, and personality fac-
tors, with the exception of neuroticism, these two groups
were merged (MTC ?) in further analyses. The intent-to-
treat principle was not followed since we were interested in
the effects of BCT and MTC on QoL. Keeping the con-
version group in the BCT group would provide blurred
information on this issue.
There were no signiﬁcant changes over time, nor sig-
niﬁcant differences between the two treatment groups for
overall QoL (Fig. 1) and the three QoL domains (physical,
psychological, and social domain).
Within the BCT group in particular, trait anxiety pre-
dicted overall QoL (Table 3). Up to 43% of variance in
scores was explained by trait anxiety (P\0.001). Other
contributing factors such as agreeableness and education
were responsible for less than 10% of variance. Twelve
months after surgery, neuroticism was the main factor of
inﬂuence in the BCT group and responsible for 34% of the
variance in QoL scores (P\0.001). Demographic factors,
the remaining personality factors, and psychological factors
did not signiﬁcantly predict overall QoL in the BCT group.
A high score on trait anxiety had a profound negative
Table 1 Demographics and clinical factors for the three treatment groups
BCT (n = 105) MTC (n = 89) BCT[MTC (n = 28) P value
Demographics
Age 58.3 (8.7/ 0.9) 58.4 (9.3/ 1.0) 58.7 (10.7/ 2.0)
Partner 88 (83.8) 69 (77.5) 22 (78.6)
Children 87 (82.9) 77 (86.5) 24 (85.7)
Educational level\10/10–14/[14 years 38 (36.9)/46 (44.7)/19 (18.4) 30 (35.7)/40 (47.6)/14 (16.7) 14 (51.9)/8 (29.6)/5 (18.5)
Paid work 40 (38.5) 37 (42.5) 9 (32.1)
Clinical factors
Tumor size radiology (mm) 14.9 (8.6) 21.0 (12.6) 17.3 (8.6) 0.001
Tumor size pathology (mm) 14.1 (6.9) 21.7 (11.1) 28.7 (19.0) \0.001
Axillary metastases 26 (25.2) 37 (42.0) 10 (35.7)
Chemotherapy 19 (18.3) 36 (40.4) 7 (25.2) 0.005
Hormone therapy 31 (29.5) 46 (51.7) 8 (28.6) 0.002
Radiotherapy 97 (92.4) 17 (19.1) 5 (17.9) \0.001
Except for age and tumor size, percentages are in parentheses. For age, standard deviation and standard error of the mean are given in
parenthesis. For the calculation of the percentage, missings are not included
Table 2 Scores on personality
factors and QoL domains at
baseline for the three treatment
groups
Scores are means. Standard
deviation is given in parenthesis
BCT MTC BCT[MTC P value
Personality
Neuroticism 30.6 (7.5) 30.2 (7.5) 26.5 (4.4) 0.044
Neuroticism high score 42.4 (3.2) 42.2 (2.2) 40.0
Neuroticism not-high score 28.3 (5.6) 28.2 (6.1) 25.9 (3.3)
Extraversion 40.6 (5.7) 41.9 (5.5) 41.5 (5.4)
Openness to experiences 36.0 (6.6) 34.9 (5.1) 35.9 (5.3)
Agreeableness 43.7 (4.3) 43.3 (4.9) 43.6 (3.1)
Conscientiousness 45.9 (5.6) 45.9 (5.3) 45.2 (5.0)
Trait anxiety 40.1 (11.1) 39.0 (11.2) 36.9 (9.5)
Trait anxiety high score 52.4 (6.6) 51.2 (5.3) 48.1 (5.1)
Trait anxiety not-high score 33.1 (5.8) 32.1 (6.9) 31.3 (5.2)
QoL domains
Overall QoL and general health 15.5 (2.4) 15.8 (2.8) 15.9 (2.0)
Physical domain 14.1 (2.5) 14.2 (2.5) 14.6 (2.1)
Psychological domain 14.7 (1.8) 14.8 (2.1) 15.0 (1.4)
Social domain 16.2 (2.2) 16.6 (2.0) 16.4 (2.1)
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sion analysis showed that the chance that patients in the
BCT group with a high score on trait anxiety experienced a
low QoL was signiﬁcantly elevated on all measurement
moments, for instance, 7.8 at 6 months postsurgery (odds
ratio [OR] = 7.81; 95% CI = 2.42-25.72; P = 0.001).
The most important factor that predicted overall QoL in
the MTC ? group was the personality characteristic neu-
roticism. It explained up to 26% of the variance in QoL
scores (Table 3). Neuroticism is the personality factor that
predicted overall QoL in the MTC ? group and thus was
included in the logistic regression analyses. For the
MTC ? group, a high score on neuroticism had a profound
and negative inﬂuence on overall QoL. The chance that
women in the MTC ? group with a high score on neuroti-
cism experienced alow QoL 6 months postsurgerywas 10.3
(OR = 10.26; 95% CI = 2.05-51.43; P = 0.0001) and
1 year postsurgery 4.4 (OR = 4.38; 95% CI = 1.02-18.90;
P = 0.048).
The percentage of patients with a high score on trait
anxiety did not differ between the patient groups. With
respect to neuroticism, the percentage of women scoring
high was low in the conversion group compared with the
BCT and MTC groups, but the scores did not differ sig-
niﬁcantly (Table 2).
Using general linear models, the impact of trait anxiety
and neuroticism on the scores of overall QoL was assessed.
The women were divided into four groups based on their
surgical treatment and their scores on one of these two
personality factors (Fig. 2). Women with high scores on
trait anxiety had signiﬁcantly lower QoL scores at all
measurement moments irrespective of surgical treatment
(P\0.001, g
2 = 0.223, observed power = 0.99). How-
ever, the differences in QoL scores were most pro-
nounced for the BCT group. Women in this group with a
low score on trait anxiety had the highest QoL scores and
the BCT women with a high score on trait anxiety had the
worst QoL scores (P\0.002 for all measurement
moments). Women with high scores on neuroticism scored
signiﬁcantly lower on overall QoL, again irrespective of
surgical treatment (P = 0.024; g
2 = 0.09, observed
power = 0.74).
Discussion
The aim of the present study was to establish the inﬂuence
of surgical treatment and personality on overall QoL. A
difference in overall QoL in favor of the BCT group was
expected. Previous studies have shown that body image is
better after BCT and that physical complaints tend to be
Fig. 1 Scores on overall quality of life and general health. Scores are
represented as means for both treatment groups
Table 3 Regression analyses
for overall QoL as dependent
variable for both treatment
groups
R
2 is the percentage of variance
in the scores of the dependent
variable explained by the
independent variable
(1.00 = 100%). A negative beta
means that a higher score of the
independent variable will result
in a lower score of the
dependent variable
Measurement moment Treatment Independent factor R
2 b P value
T2 BCT Trait anxiety 0.29 –0.53 \0.001
MTC? Neuroticism 0.19 –0.43 \0.001
T3 BCT Trait anxiety 0.37 –0.61 \0.001
Conscientiousness 0.09 0.30 0.004
Agreeableness 0.04 0.23 0.037
MTC? Neuroticism 0.21 –0.45 \0.001
Radiotherapy 0.08 –0.28 0.009
T4 BCT Trait anxiety 0.43 –0.66 \0.001
Education 0.11 0.33 0.005
Agreeableness 0.06 0.24 0.015
MTC? Neuroticism 0.20 –0.44 \0.001
Radiotherapy 0.10 –0.31 0.004
T5 BCT Neuroticism 0.34 –0.58 \0.001
Education 0.09 0.30 0.011
MTC? Neuroticism 0.26 –0.51 \0.001
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123less severe following BCT [19]. However, in the present
study no signiﬁcant differences were observed between the
two treatment groups for either the scores on overall QoL
or the QoL domain scores. The contrast of these results
with expectations may be explained by the questionnaires
used to measure QoL. When analyzing previous studies
concerning QoL in breast cancer patients, the vast majority
did not use QoL questionnaires but measured health status
(HS) [20]. QoL and HS are often considered interchange-
able, but the concepts differ considerably. HS reﬂects
solely the functioning in the physical, psychological, and
social domains and does not focus on the subjective sat-
isfaction of the individual [21], whereas QoL revolves
entirely around the contentment with functioning. Apply-
ing a HS questionnaire and a QoL questionnaire to the
same study population will lead to different outcome scores
[22].
With regard to the inﬂuence of personality on overall
QoL scores, a profound inﬂuence of anxiety was expected
due to fear of recurrence of cancer. Nowadays, there is
general agreement about the view that personality, at least
for descriptions at a rather global level, can be described
adequately in terms of the Big Five dimensions: neuroti-
cism, extraversion, openness to experience, agreeableness,
and conscientiousness [23].
Neuroticism is an important and extensive domain. It
weighs emotional instability against emotional stability,
i.e., the tendency to experience no distressing emotions
such as fear, guilt, and frustration. Extraversion concerns
the degree in which energy, orientation, and attention are
focused on the outside world in contrast to the inner world.
Openness refers to an open attitude towards other people,
beliefs, and experiences. Agreeableness represents one’s
orientation towards experiences, goals, and interests of
other people. Conscientiousness refers directly to the
conscience as a guiding and analyzing instrument for one’s
own behavior [13]. Anxiety can be considered a part of the
neuroticism domain, but it can also be deﬁned individually.
Trait anxiety refers to the tendency to respond to situations
perceived as threatening with a rise in anxiety intensity
[14].
As expected, trait anxiety was indeed a strong predictor
of overall QoL, but only in the BCT group. When women
were divided into four groups based on their scores on
anxiety and surgical treatment, trait anxiety turned out to
have more impact on QoL than surgical treatment. These
ﬁndings imply that the beneﬁcial effects of BCT on body
image and presumably on overall QoL are negated in
women who experience anxiety.
For the MTC ? group, the personality trait neuroticism
had signiﬁcant inﬂuence on the overall QoL and, again, this
inﬂuence exceeded the inﬂuence of surgical treatment.
However, the effect of neuroticism on overall quality of
life was not as strong as the effect of trait anxiety.
It may be that the 28 women who chose a BCT but
ended up with a mastectomy inﬂuenced the aforementioned
results. However, we would expect these women to have a
negative inﬂuence on the outcomes of the MTC ? group.
Instead, lower scores were found in the BCT group. In
addition, no signiﬁcant differences were found between the
three patient groups (BCT, conversion, and MTC) at
baseline. Therefore, we feel that this potential bias did not
inﬂuence the results presented.
Previous studies have shown that anxiety is a deter-
mining factor in QoL. Fear of the future, fear of dying, and
fear of recurrence of cancer all have a profound inﬂuence
Fig. 2 Scores on overall quality of life and general health for a trait
anxiety and b neuroticism. Scores are represented as means. Patients
were divided into four groups based on their surgical treatment (BCT
vs. MTC) and their scores on the given personality trait (high score
vs. not-high score) In (a), the standard error of the means (SEM) did
not exceed 0.6. In (b), the SEM was on measurement moment 4
between 1.0 and 1.3; for the other moments it did not go higher than
0.3
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123on QoL [24]. Several studies have looked into personality
and psychological health in women with breast cancer and
conﬁrmed a negative inﬂuence of depression and anxiety
[24–26] and neuroticism [27, 28] on QoL and psychosocial
adjustment to the diagnosis breast cancer. However, none
of these studies included surgical treatment as a variable of
inﬂuence.
Studies performed by Ormel et al. [29, 30] showed that
personality is more powerful for predicting psychological
distress than external events such as diseases or inadvertent
life events. Thus, the strong inﬂuence of personality on
subjective well-being in general and on coping mecha-
nisms in the case of adverse life events has now been found
for breast cancer patients as well.
In conclusion, QoL in breast cancer patients is not
signiﬁcantly inﬂuenced by surgical treatment but mainly
by personality, especially the factors of trait anxiety,
neuroticism, and extraversion. The diminished QoL in
BCT patients who score high on trait anxiety is especially
important since these ﬁndings bring up questions about
treatment choice. Women in the BCT group turned out to
have smaller tumors, less axillary metastases, and, thus,
less adjuvant treatment. The fact that they had a less
mutilating surgical procedure compared with MTC, would
not experience the adverse effects of adjuvant treatment,
and, statistically speaking, would have the best prognosis
concerning survival, should result in a better QoL. How-
ever, this better QoL could not be conﬁrmed, and, even
worse, women with certain personality traits would have
been better off having MTC. So far, clinics have been
judged by the percentage of breast-conserving surgeries
performed for early-stage breast cancer. However, in the
decision process the personality of women diagnosed with
breast cancer has never been taken into consideration.
Based on our results, we feel that personality factors
should be incorporated into the advice given to women
when they choose between MTC and BCT and that women
scoring high on trait anxiety should be made aware of the
possible negative inﬂuence of their personality on their
experienced QoL when they choose BCT. When these
women choose BCT after being well informed, it is
important to offer them psychosocial support and coun-
seling to help them live and cope with their fears. Future
studies that look at personality factors and evaluate psy-
chosocial interventions are needed to examine the gener-
alizability of our results.
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